India’s Bharat Biotech has applied to conduct trials in Bangladesh for its coronavirus vaccine recently approved for emergency use at home, a senior official at Bangladesh’s main medical research body told Reuters.
If allowed to go ahead, this would be the first trial of any coronavirus vaccine in Bangladesh and could give the densely populated country of more than 160 million faster access to the shot for mass use.
“We have received their proposal,” said Mahmood-uz-Jahan, a director at the state-run Bangladesh Medical Research Council, adding that its ethics committee would review the application.
